Michael Buck, PhD, professor of biochemistry in the Jacobs School, recently received NIH funding to explore how molecular readers of DNA access and activate seemingly hidden genes.
Interview with Kunal Agarwal’s founder and CEO of dope.security, featured in SecurityWeek's Hacker Conversations Series.
In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback